Table of Contents
ISR’s “CRO Quality Benchmarking – Phase IV Service Providers” report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. Respondents supplied performance ratings based on their own experiences with 44 Phase IV CROs, making this report the most comprehensive assessment of CRO service quality in the industry. Now in its 8th year, this report has become a crucial tool for sponsors looking to select a Phase IV CRO and for service providers seeking an experience-based evaluation of their strengths and weaknesses.
How you can use this report
- Make a more informed purchase of Phase IV services by understanding which service providers best fit your company’s needs
- Broaden your Phase IV CRO evaluation list by accessing peer-based service quality ratings across 26 critical attributes
- Pinpoint potential delivery concerns early in a sponsor
- CRO relationship/ evaluation in order to develop proactive strategies to address potential gaps
CLINICAL SERVICE PROVIDERS
- Uncover your own - and competitor - delivery strengths and weaknesses
- Design messaging to tout your company’s strengths
- Compete more effectively by understanding buyers’ selection criteria and outsourcing trends
Make a more informed purchase of Phase IV CRO services by understanding which service providers best fit your company’s needs.
Uncover your perceived strengths and weaknesses based on customer reviews, and compare your services to those of your competitors.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years- Examines trends in the U.S., Europe and Japan- Reviews current and emerging ...
Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...
This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...